Sign in to fuzzto save your conversations, follow your research and come back anytime.
Shree Pushkar Chemicals
SHREEPUSHK
NSE
BSE
NSEBSESectorChemicals
477.45
Loading chart…
NSEBSEThe Quarter story
The two most recent quarterly results, compared side-by-side.
Earnings recover in Q1 FY27 with revenue at ₹280 Cr and margins stabilizing, while rising material costs and finance charges need attention.
Consolidated revenue grew from ₹255 Cr in Q1 FY26 to ₹280 Cr in Q1 FY27, driven by steady sales momentum.
Consolidated cost of materials consumed rose from ₹151.2 Cr in Q1 FY26 to ₹193.4 Cr in Q1 FY27, highlighting input cost inflation.
Consolidated EBITDA margin recovered from 8.9% in Q3 FY26 to 11.4% in Q1 FY27, restoring pricing power.
Consolidated finance costs jumped from ₹0.7 Cr in Q3 FY26 to ₹2.6 Cr in Q1 FY27, warning of debt pressure.
Fertilisers sales volume contribution surged from 67% in Q3 FY26 to 88% in Q1 FY27, highlighting segment dominance.
Chemicals sales volume dropped from 32,103 MT in Q2 FY26 to 13,725 MT in Q4 FY26, reflecting seasonal demand shifts.
Consolidated capital work in progress expanded from ₹13 Cr in Q1 FY26 to ₹149.4 Cr in Q4 FY26, signaling active capacity upgrades.
Chemicals revenue fell from ₹249 Cr in Q2 FY26 to ₹126 Cr in Q4 FY26, signaling demand normalization.
Consolidated PAT climbed from ₹18 Cr in Q3 FY26 to ₹23 Cr in Q1 FY27, confirming earnings recovery.